Exemestane

CHEMBL1200374 Phase 4 Approved Small molecule
Half-Life
Bioavailability
Protein Binding
Molecular Weight
296.4 g/mol
LogP
3.1
Phase
4

This medication blocks an enzyme called aromatase that converts other hormones into estrogen, reducing estrogen levels in postmenopausal women to slow the growth of hormone-sensitive breast cancer. It is used to treat estrogen receptor-positive breast cancer.

Molecular Weight

296.4000 g/mol

LogP

3.10

TPSA

34.10 Ų

Lipinski RO5

Pass

Therapeutic Areas

Pharmacokinetics (PK)

Pharmacodynamics (PD)

2D Structure

SVG PNG

Cite this structure


                        

Embed this structure


                        

SMILES

C=C1C[C@@H]2[C@H](CC[C@]3(C)C(=O)CC[C@@H]23)[C@@]2(C)C=CC(=O)C=C12

InChI

InChI=1S/C20H24O2/c1-12-10-14-15-4-5-18(22)20(15,3)9-7-16(14)19(2)8-6-13(21)11-17(12)19/h6,8,11,14-16H,1,4-5,7,9-10H2,2-3H3/t14-,15-,16-,19+,20-/m0/s1

Molecular Formula

C20H24O2

HBD / HBA

- / 2

Rotatable Bonds

0

Heavy Atoms

22

No targets recorded

Target interaction data is not yet available for this drug.

No interactions recorded

Drug interaction data is not yet available for this compound.

No side effects recorded

Side effect data is not yet available for this drug.

Frequently Asked Questions

This medication blocks an enzyme called aromatase that converts other hormones into estrogen, reducing estrogen levels in postmenopausal women to slow the growth of hormone-sensitive breast cancer. It is used to treat estrogen receptor-positive breast cancer.

Yes, Exemestane is an approved drug. It has reached clinical phase 4. It is classified as a Small molecule.

{# References & Data Sources section for drug detail pages. Renders standard pharmacological database links plus the drug's data_sources field. #}

References & Data Sources

  • ChEMBL — European Bioinformatics Institute (EBI). CHEMBL1200374. Open-access bioactivity database.
  • PubChem — National Center for Biotechnology Information (NCBI). CID 60198. Chemical information database.

Data aggregated from publicly available pharmacological databases. Last updated 2026-03-04.

Medical Disclaimer

This content is for educational and informational purposes only. It is not a substitute for professional medical advice, diagnosis, or treatment. Always consult a qualified healthcare provider before making medication decisions.

Data sources: ChEMBL, PubChem, DailyMed.